Status:
COMPLETED
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
This is a prospective study of surgically resected samples and lymph nodes of lung cancer patients. For histopathologically positive lymph nodes from a complete resection, the investigators would like...
Detailed Description
Genetic: It is a prospective study during two years with three years for follow-up. No control group is recruited.
Eligibility Criteria
Inclusion
- Patients with resectable non-small cell lung cancer (stage I to IIIA), with a complete resection of the tumor and paired lymph nodes.
- Informed consent is required.
Exclusion
- Another cancer
- Chemotherapy before surgical treatment
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00213733
Start Date
June 1 2004
End Date
August 1 2011
Last Update
August 30 2011
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Thoracique, Hôpital Civil
Strasbourg, France, 67091
2
Service de Pneumologie, Hôpital Lyautey
Strasbourg, France, 67091
3
Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre
Strasbourg, France, 67098
4
Service d'Anatomie Pathologique, Hôpital de Hautepierre
Strasbourg, France, 67098